Hager & Partners Advises Borromin Capital and Protect Medical Group on Acquisition of CA‑MI

Hager & Partners represented Borromin Capital and the Protect Medical Group in the acquisition of CA‑MI, with RSM Ebner Stolz collaborating on tax and financial due diligence; CA‑MI and its shareholders were assisted by Andrea Fiorucci and Paolo Damini. The transaction concerns the acquisition by Protect Medical, controlled by Borromin Capital Management (Frankfurt-based private equity firm), of CA‑MI, an Italian family-owned company headquartered in Parma and active since 1984 in the manufacture and commercialization of electromedical devices and medical equipment. CA‑MI is internationally recognised as a specialist in respiratory therapy, suction technology, diagnostics, rehabilitation and wellness. Through its in-house R&D department, CA‑MI manufactures its compressors, aspirators and nebulizers entirely in Italy and exports to over 100 countries. Borromin Capital Management, founded in 2001 and focused on mid-market investments across the D‑A‑CH region and the Benelux, pursues a value-oriented private equity strategy aimed at supporting profitable companies through generational transitions, management buy-outs and growth initiatives. Hager & Partners represented Borromin Capital and the Protect Medical Group with a team composed by: David Covi (partner in charge, M&A Legal), Martin Grandi (project lead, M&A Legal); Romana Taibon (partner in charge, M&A Tax) and Luigi Manfredi (project pead, M&A Tax). RSM Ebner Stolz assisted the buyer on tax and financial due diligence and the definition of the transaction structure with a team composed by: Alexander Euchner (partner in charge, M&A Tax) and Dennis Kieß (project lead, M&A Tax). Andrea Fiorucci and Paolo Damini represented CA‑MI and its shareholders.

Hager & Partners Advises Borromin Capital and Protect Medical Group on Acquisition of CA‑MI

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads